Loan & DebtJun 17, 2026, 06:07 AM
NeoGenomics Prices $275M Convertible Notes Offering
AI Summary
NeoGenomics, Inc. announced the pricing of its offering of $275 million in aggregate principal amount of 0.75% convertible senior notes due 2032. The offering, made to qualified institutional buyers, includes an option for an additional $41.25 million. The company also plans to use a portion of the net proceeds to repurchase $276 million of its existing convertible senior notes due 2028 and up to $25 million of its common stock.
Key Highlights
- NeoGenomics priced a $275 million offering of 0.75% convertible senior notes due 2032.
- The company granted an option to purchase an additional $41.25 million in notes.
- Initial conversion price is approximately $14.16 per share, a 35% premium to the June 16 closing price.
- NeoGenomics expects net proceeds of approximately $266.15 million from the offering.
- The company intends to use approximately $25 million for capped call transactions.
- NeoGenomics will use a portion of proceeds to repurchase $276 million of existing 0.25% convertible senior notes due 2028.
- Up to $25 million of remaining proceeds may be used to repurchase common stock.
Price Impact
More from NEO